These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34649753)

  • 1. Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic: Did age make the difference?
    Trevisan C; Pedone C; Maggi S; Noale M; Di Bari M; Sojic A; Molinaro S; Giacomelli A; Bianchi F; Tavio M; Rusconi S; Pagani G; Galli M; Prinelli F; Adorni F; Antonelli Incalzi R;
    Health Policy; 2021 Dec; 125(12):1580-1586. PubMed ID: 34649753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Related Changes in Clinical Presentation of Covid-19: the EPICOVID19 Web-Based Survey.
    Trevisan C; Noale M; Prinelli F; Maggi S; Sojic A; Di Bari M; Molinaro S; Bastiani L; Giacomelli A; Galli M; Adorni F; Antonelli Incalzi R; Pedone C;
    Eur J Intern Med; 2021 Apr; 86():41-47. PubMed ID: 33579579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey.
    Adorni F; Prinelli F; Bianchi F; Giacomelli A; Pagani G; Bernacchia D; Rusconi S; Maggi S; Trevisan C; Noale M; Molinaro S; Bastiani L; Fortunato L; Jesuthasan N; Sojic A; Pettenati C; Tavio M; Andreoni M; Mastroianni C; Antonelli Incalzi R; Galli M
    JMIR Public Health Surveill; 2020 Sep; 6(3):e21866. PubMed ID: 32650305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Smoking and SARS-CoV-2 Infection: Cross-sectional Study of the EPICOVID19 Internet-Based Survey.
    Prinelli F; Bianchi F; Drago G; Ruggieri S; Sojic A; Jesuthasan N; Molinaro S; Bastiani L; Maggi S; Noale M; Galli M; Giacomelli A; Antonelli Incalzi R; Adorni F; Cibella F;
    JMIR Public Health Surveill; 2021 Apr; 7(4):e27091. PubMed ID: 33668011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid COVID-19 Screening Based on Self-Reported Symptoms: Psychometric Assessment and Validation of the EPICOVID19 Short Diagnostic Scale.
    Bastiani L; Fortunato L; Pieroni S; Bianchi F; Adorni F; Prinelli F; Giacomelli A; Pagani G; Maggi S; Trevisan C; Noale M; Jesuthasan N; Sojic A; Pettenati C; Andreoni M; Antonelli Incalzi R; Galli M; Molinaro S
    J Med Internet Res; 2021 Jan; 23(1):e23897. PubMed ID: 33320825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex- and gender-related differences linked to SARS-CoV-2 infection among the participants in the web-based EPICOVID19 survey: the hormonal hypothesis.
    Prinelli F; Trevisan C; Noale M; Franchini M; Giacomelli A; Cori L; Jesuthasan N; Incalzi RA; Maggi S; Adorni F;
    Maturitas; 2022 Apr; 158():61-69. PubMed ID: 35241240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients.
    Catalano A; Dansero L; Gilcrease W; Macciotta A; Saugo C; Manfredi L; Gnavi R; Strippoli E; Zengarini N; Caramello V; Costa G; Sacerdote C; Ricceri F
    JMIR Public Health Surveill; 2023 Feb; 9():e41404. PubMed ID: 36626821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection: Data from the EPICOVID19 Web-Based Survey.
    Noale M; Trevisan C; Maggi S; Antonelli Incalzi R; Pedone C; Di Bari M; Adorni F; Jesuthasan N; Sojic A; Galli M; Giacomelli A; Molinaro S; Bianchi F; Mastroianni C; Prinelli F; Group OBOTEW
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32842505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test.
    Sun Q; Li J; Ren H; Pastor L; Loginova Y; Madej R; Taylor K; Wong JK; Zhang Z; Zhang A; Lu CM; Sha MY
    PLoS One; 2021; 16(2):e0243183. PubMed ID: 33621263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 pandemic and Construction Industry: insights from Italian data.
    Riccò M
    Acta Biomed; 2022 Jul; 93(3):e2022233. PubMed ID: 35775779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study.
    Adorni F; Jesuthasan N; Perdixi E; Sojic A; Giacomelli A; Noale M; Trevisan C; Franchini M; Pieroni S; Cori L; Mastroianni CM; Bianchi F; Antonelli-Incalzi R; Maggi S; Galli M; Prinelli F; On Behalf Of The Epicovid Working Group
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.